On 05 February 2026, PW Medtech Group Limited (stock code: 01358) released a Next Day Disclosure Return. The total number of issued shares remained at 1,473,589,098, with no change from the opening to the closing balance.

According to the document, a share repurchase was conducted on 05 February 2026 involving 543,000 shares on the Hong Kong Stock Exchange, at prices ranging from HKD 1.29 to HKD 1.30, for a total consideration of HKD 705,340. These repurchased shares, along with other previously repurchased shares, have not yet been cancelled.

The repurchase mandate was granted on 10 June 2025, authorizing up to 148,673,509 shares for repurchase. As of the date of the Return, 17,258,000 shares had been repurchased under the mandate, representing approximately 1.1608% of the issued share capital at the time the mandate was approved. A 30-day moratorium on new share issuances or transfers of treasury shares is in place after the repurchase, ending on 07 March 2026.